DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo

MannKind Corp (NASDAQ: MNKD)

3.69 -0.16 (-4.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $3.69 -4.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.85
Previous Close $3.85
Daily Range $3.69 - $3.89
52-Week Range $3.25 - $7.88
Market Cap $1.5B
P/E Ratio -11.67
Dividend (Yield) $0.00 (0.0%)
Volume 3,025,534
Average Daily Volume 5,664,844
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

5 Things MannKind Corporation's Management Team Wants You To Know

Management had a lot of information to share with investors when it reported second quarter earnings. Here are 5 key takeaways.

Watch For A Potential 50% Drop In Omeros

4 Not-Too-Scary Ways to Make Money on Biotech Stocks

Here's how you can invest in biotech without too much fear.

Yahoo Reflects No Value Other Than Alibaba - Cramer's Lightning Round (8/27/15)

'Mad Money' Lightning Round: You're OK With Yahoo! and Home Depot

MannKind: The Stock Where Tomorrow Never Arrives

Why Sanofi Deserves A Second Look

3 Reasons Why Afrezza's Launch Has Been So Disappointing

Management blames its slow start for Afrezza, the company's inhaled insulin and only approved drug, on these three factors.

What's Behind Sanofi's Afrezza Pediatric Study For MannKind?

MannKind Corporation: Afrezza Is Broadly Covered

See More MNKD News...

MNKD's Top Competitors

MNKD $3.69 (-4.16%)
Current stock: MNKD
AMGN $149.23 (-2.01%)
Current stock: AMGN
GILD $101.91 (-2.26%)
Current stock: GILD
BIIB $301.63 (-0.85%)
Current stock: BIIB